Asthmanefrin

— THERAPEUTIC CATEGORIES —
  • Asthma/COPD

Asthmanefrin Generic Name & Formulations

General Description

Racepinephrine 2.25%; inh soln.

Pharmacological Class

Sympathomimetic.

How Supplied

Starter Kit—1 (10 vials + 1 EZ Breathe Atomizer); Refill vials—30

Generic Availability

NO

Asthmanefrin Indications

Indications

For temporary relief of shortness of breath, tightness of chest, and wheezing due to bronchial asthma.

Asthmanefrin Dosage and Administration

Adults and Children

For use in an atomizer (eg, EZ Breathe Atomizer). Add contents of one vial (0.5mL) to atomizer. <4yrs: not recommended. ≥4yrs: 1–3 inhalations not more than every 3 hours.

Asthmanefrin Contraindications

Contraindications

Within 14 days of MAOIs.

Asthmanefrin Boxed Warnings

Not Applicable

Asthmanefrin Warnings/Precautions

Warnings/Precautions

Heart disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Asthma requiring hospitalization. Discontinue and reevaluate if symptoms are not relieved within 20 minutes or worsen. Do not use if product is brown, pinkish or darker than slightly yellow in color, if it appears cloudy, or if it contains a precipitate. Pregnancy. Nursing mothers.

Asthmanefrin Pharmacokinetics

See Literature

Asthmanefrin Interactions

Interactions

Caution with concomitant other asthma drugs.

Asthmanefrin Adverse Reactions

Adverse Reactions

Nervousness, tachycardia with excessive use.

Asthmanefrin Clinical Trials

See Literature

Asthmanefrin Note

Not Applicable

Asthmanefrin Patient Counseling

See Literature